Lista de obras - Eddy Pasquier - Dominio Público Uruguay

A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens

artículo científico publicado en 2013

Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells

artículo científico publicado en 2005

Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells

artículo científico publicado en 2006

Can targeted therapy be successful without metronomic scheduling?

artículo científico

Caulerpenyne-colchicine hybrid: synthesis and biological evaluation.

artículo científico publicado en 2006

Children treated with metronomic chemotherapy in a low-income country: METRO-MALI-01.

artículo científico publicado en 2011

Chimiothérapie métronomique en oncologie pédiatrique : effet de mode ou espoir réel ?

artículo científico publicado en 2009

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

artículo científico publicado en 2007

Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer

artículo científico publicado en 2014

Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?

artículo científico publicado en 2018

ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties

artículo científico publicado en 2010

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study

artículo científico publicado en 2016

Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization.

artículo científico publicado en 2012

For cancer, seek and destroy or live and let live?

artículo científico publicado en 2009

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

artículo científico publicado en 2013

Has the time come for metronomics in low-income and middle-income countries?

artículo científico

In silico molecular target prediction unveils Mebendazole as a potent MAPK14 inhibitor

scientific article published on 05 October 2020

Investment in cancer studies in countries of low and middle income

artículo científico publicado en 2013

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

artículo científico publicado en 2014

Looking at the Seemingly Contradictory Role of Vinblastine in Anaplastic Large-Cell Lymphoma From a Metronomic Perspective

artículo científico publicado en 2010

MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions

artículo científico publicado en 2010

Metronomic Chemotherapy Regimens Using Microtubule-Targeting Agents: Mechanisms of Action, Preclinical Activity and Future Developments

Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists

artículo científico publicado en 2019

Metronomic chemotherapy-induced bilateral subdural hematoma in a child with meningeal carcinomatosis.

artículo científico publicado en 2009

Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: a preliminary monocentric study

artículo científico publicado en 2008

Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.

artículo científico

Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?

artículo científico publicado en 2011

Metronomics during palliative care in paediatric oncology? For sure! But handle me with care

scientific article published on 01 August 2016

Metronomics in low and middle income countries: India showing the way!

artículo científico publicado en 2013

Metronomics: Potential Social Impact and New Business Models to Improve Availability of Cancer Treatments

Metronomics: towards personalized chemotherapy?

artículo científico publicado en 2014

Microtubule-targeting agents in angiogenesis: where do we stand?

artículo científico publicado en 2006

Microtubules: a dynamic target in cancer therapy.

artículo científico publicado en 2008

Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.

artículo científico publicado en 2011

Paediatrics: Metronomics - fulfilling unmet needs beyond level A evidence

artículo científico publicado en 2016

Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy

artículo científico publicado en 2017

Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.

artículo científico publicado en 2013

R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma

scientific article published on 30 July 2019

Reply: Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'--β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs

artículo científico publicado en 2013

Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer'

article

Synthesis of novel isoflavene-propranolol hybrids as anti-tumor agents.

artículo científico publicado en 2013

Synthesis, anti-cancer and anti-inflammatory activity of novel 2-substituted isoflavenes.

artículo científico publicado en 2014

Synthesis, biological evaluation and structure-activity relationship studies of isoflavene based Mannich bases with potent anti-cancer activity.

artículo científico publicado en 2015

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

artículo científico publicado en 2015

Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment.

artículo científico publicado en 2007

The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis

artículo científico publicado en 2004

The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression

artículo científico publicado en 2016

Tubulin proteomics: towards breaking the code.

artículo científico publicado en 2008

Understanding microtubule dynamics for improved cancer therapy.

artículo científico publicado en 2005

β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.

artículo científico publicado en 2013

γ-Actin plays a key role in endothelial cell motility and neovessel maintenance

artículo científico publicado en 2015

γ-Actin regulates cell migration and modulates the ROCK signaling pathway

artículo científico publicado en 2011

Lista de obras de Eddy Pasquier

A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens

Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells

Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells

Can targeted therapy be successful without metronomic scheduling?

Caulerpenyne-colchicine hybrid: synthesis and biological evaluation.

Children treated with metronomic chemotherapy in a low-income country: METRO-MALI-01.

Chimiothérapie métronomique en oncologie pédiatrique : effet de mode ou espoir réel ?

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer

Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?

ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study

Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization.

For cancer, seek and destroy or live and let live?

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

Has the time come for metronomics in low-income and middle-income countries?

In silico molecular target prediction unveils Mebendazole as a potent MAPK14 inhibitor

Investment in cancer studies in countries of low and middle income

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

Looking at the Seemingly Contradictory Role of Vinblastine in Anaplastic Large-Cell Lymphoma From a Metronomic Perspective

MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions

Metronomic Chemotherapy Regimens Using Microtubule-Targeting Agents: Mechanisms of Action, Preclinical Activity and Future Developments

Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists

Metronomic chemotherapy-induced bilateral subdural hematoma in a child with meningeal carcinomatosis.

Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: a preliminary monocentric study

Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.

Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?

Metronomics during palliative care in paediatric oncology? For sure! But handle me with care

Metronomics in low and middle income countries: India showing the way!

Metronomics: Potential Social Impact and New Business Models to Improve Availability of Cancer Treatments

Metronomics: towards personalized chemotherapy?

Microtubule-targeting agents in angiogenesis: where do we stand?

Microtubules: a dynamic target in cancer therapy.

Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.

Paediatrics: Metronomics - fulfilling unmet needs beyond level A evidence

Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy

Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.

R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma

Reply: Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'--β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs

Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer'

Synthesis of novel isoflavene-propranolol hybrids as anti-tumor agents.

Synthesis, anti-cancer and anti-inflammatory activity of novel 2-substituted isoflavenes.

Synthesis, biological evaluation and structure-activity relationship studies of isoflavene based Mannich bases with potent anti-cancer activity.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment.

The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis

The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression

Tubulin proteomics: towards breaking the code.

Understanding microtubule dynamics for improved cancer therapy.

β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.

γ-Actin plays a key role in endothelial cell motility and neovessel maintenance

γ-Actin regulates cell migration and modulates the ROCK signaling pathway